JP5587168B2 - Cleaning composition for medical equipment - Google Patents
Cleaning composition for medical equipment Download PDFInfo
- Publication number
- JP5587168B2 JP5587168B2 JP2010292238A JP2010292238A JP5587168B2 JP 5587168 B2 JP5587168 B2 JP 5587168B2 JP 2010292238 A JP2010292238 A JP 2010292238A JP 2010292238 A JP2010292238 A JP 2010292238A JP 5587168 B2 JP5587168 B2 JP 5587168B2
- Authority
- JP
- Japan
- Prior art keywords
- cleaning
- cleaning composition
- mass
- medical
- medical devices
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004140 cleaning Methods 0.000 title claims description 68
- 239000000203 mixture Substances 0.000 title claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims description 22
- -1 ethanediyloxy group Chemical group 0.000 claims description 20
- 239000002736 nonionic surfactant Substances 0.000 claims description 14
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 150000005846 sugar alcohols Polymers 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000007865 diluting Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 14
- 125000000217 alkyl group Chemical group 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 108091005658 Basic proteases Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 239000012459 cleaning agent Substances 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 238000005260 corrosion Methods 0.000 description 6
- 230000007797 corrosion Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229920001515 polyalkylene glycol Polymers 0.000 description 4
- 230000002797 proteolythic effect Effects 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 108090000787 Subtilisin Proteins 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- VERMEZLHWFHDLK-UHFFFAOYSA-N tetrahydroxybenzene Natural products OC1=CC=C(O)C(O)=C1O VERMEZLHWFHDLK-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- KRGXWTOLFOPIKV-UHFFFAOYSA-N 3-(methylamino)propan-1-ol Chemical compound CNCCCO KRGXWTOLFOPIKV-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000006382 Bacillus halodurans Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-O N-dimethylethanolamine Chemical compound C[NH+](C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-O 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229920002004 Pluronic® R Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000007743 anodising Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- WWYKBCRVBABKLC-UHFFFAOYSA-N hexane-1,1,1,2-tetrol Chemical compound CCCCC(O)C(O)(O)O WWYKBCRVBABKLC-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 238000011086 high cleaning Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- HFWWEMPLBCKNNM-UHFFFAOYSA-N n-[bis(hydroxyamino)methyl]hydroxylamine Chemical compound ONC(NO)NO HFWWEMPLBCKNNM-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- URKBBEIOEBOBIY-UHFFFAOYSA-N pentane-1,1,1,2-tetrol Chemical compound CCCC(O)C(O)(O)O URKBBEIOEBOBIY-UHFFFAOYSA-N 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 description 1
- 229940074439 potassium sodium tartrate Drugs 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- RWVGQQGBQSJDQV-UHFFFAOYSA-M sodium;3-[[4-[(e)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-n-ethyl-3-methylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=C1 RWVGQQGBQSJDQV-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
Description
本発明は、医療器具用洗浄剤組成物及び医療器具の洗浄方法に関する。 The present invention relates to a cleaning composition for medical devices and a cleaning method for medical devices.
医療器具は使用後に洗浄、消毒した後に再使用されている。洗浄が不十分であると、消毒効果が下がることから、医療器具用洗浄剤としては、高い洗浄力が必要である。一方、医療器具の中にはアルマイト等、腐食しやすい材料を用いた部材も使用されている。医療器具は繰り返し洗浄消毒し再使用されるが、洗浄により表面に腐食が生じると、医療器具が再使用できなくなってしまうという問題があった。特に、内視鏡のような非常に高価な医療器具では、著しい問題となる。 Medical devices are reused after cleaning and disinfection after use. If the cleaning is insufficient, the disinfecting effect is lowered, so that a high cleaning power is required as a medical device cleaning agent. On the other hand, members using materials that easily corrode such as anodized are also used in medical instruments. Medical devices are repeatedly cleaned and disinfected and reused. However, if the surface is corroded by cleaning, there is a problem that the medical devices cannot be reused. This is particularly a problem with very expensive medical instruments such as endoscopes.
特許文献1には、ポリオキシエチレン−ポリオキシプロピレンブロックポリマー、ポリオキシアルキレンアルキルエーテル、アルカノールアミン、無機アルカリ剤を含有する医療器具用洗浄剤組成物が開示されている。このような洗浄剤を用いると、繰り返し洗浄していると次第にアルマイト部分に腐蝕を生じてしまう。アルマイト等の腐食防止を目的とした技術として、特許文献2には、アルカリ成分と3〜8価の多価アルコール等の特定の水酸基含有成分とからなるアルカリ洗浄剤が開示されている。しかしながら、フォトレジスト等の半導体用に原液で使用されるタイプの洗浄剤であり医療器具洗浄では、50〜1000倍に希釈して使用することから、この組成は医療器具洗浄に用いても、洗浄力とアルマイト防食を両立することはできない。特許文献2は液晶パネル等の電子部品の洗浄に用いられる洗浄剤であり、また希釈することなく使用されるものである。一方、医療器具洗浄機では、洗浄剤は、100〜500倍に希釈して使用することが一般的であり、使用方法、濃度が全く異なる。特許文献3には、特定の二塩基酸、アルカノールアミン、ケイ酸塩を含有する添加剤を、アルミニウム製品の洗浄剤に用いることが開示されている。しかし、特許文献3のアルカリ洗浄剤組成物は、凝固血液などの固着タンパク汚れを十分に洗浄することはできない。このように、医療器具洗浄機用洗浄剤として凝固血液の洗浄力に優れ、かつアルマイト等の金属防食性に優れたものは、従来、見出されていなかった。 Patent Document 1 discloses a cleaning composition for medical devices containing a polyoxyethylene-polyoxypropylene block polymer, a polyoxyalkylene alkyl ether, an alkanolamine, and an inorganic alkali agent. When such a cleaning agent is used, the alumite portion is gradually corroded when repeatedly cleaned. As a technique for the purpose of preventing corrosion of alumite or the like, Patent Document 2 discloses an alkaline cleaner comprising an alkali component and a specific hydroxyl group-containing component such as a tri- to octavalent polyhydric alcohol. However, it is a type of cleaning agent used in undiluted solutions for semiconductors such as photoresists. In medical equipment cleaning, it is diluted 50 to 1000 times, so this composition can be used for cleaning medical equipment. There is no balance between strength and anodizing. Patent Document 2 is a cleaning agent used for cleaning an electronic component such as a liquid crystal panel, and is used without dilution. On the other hand, in a medical instrument washer, the detergent is generally used diluted 100 to 500 times, and the usage method and concentration are completely different. Patent Document 3 discloses that an additive containing a specific dibasic acid, alkanolamine, or silicate is used as a cleaning agent for aluminum products. However, the alkaline detergent composition of Patent Document 3 cannot sufficiently wash fixed protein stains such as coagulated blood. As described above, no cleaning agent for a medical instrument washer has been found so far that has excellent coagulating blood detergency and excellent metal anticorrosive properties such as alumite.
本発明の課題は、洗浄力に優れ、かつアルマイト等の金属防食性に優れた医療器具用洗浄剤組成物及び医療器具の洗浄方法を提供することである。 The subject of this invention is providing the washing | cleaning composition for medical devices which was excellent in the detergency, and excellent in metal anticorrosion property, such as alumite, and the cleaning method of a medical device.
本発明は、(A)アルカノールアミン〔以下、(A)成分という〕3〜30質量%、(B)非イオン界面活性剤〔以下、(B)成分という〕0.5〜20質量%、(C)4価以上の多価アルコール〔以下、(C)成分という〕3〜50質量%を含有する医療器具用洗浄剤組成物に関する。 The present invention comprises (A) alkanolamine (hereinafter referred to as component (A)) 3 to 30% by mass, (B) nonionic surfactant (hereinafter referred to as component (B)) 0.5 to 20% by mass, ( C) It is related with the cleaning composition for medical devices containing 3-50 mass% of polyhydric alcohol more than tetravalence [henceforth (C) component].
また、本発明は、上記本発明の医療器具用洗浄剤組成物を水で50〜1000倍に希釈した希釈洗浄液を用いる、医療器具洗浄機による医療器具の洗浄方法に関する。 The present invention also relates to a method for cleaning a medical instrument using a medical instrument washer using a diluted cleaning solution obtained by diluting the cleaning composition for a medical instrument of the present invention 50 to 1000 times with water.
本発明によれば、洗浄力に優れ、かつアルマイト等の金属防食性に優れた医療器具用洗浄剤組成物及び医療器具の洗浄方法が提供される。 ADVANTAGE OF THE INVENTION According to this invention, the washing | cleaning composition for medical devices which was excellent in the detergency and was excellent in metal corrosion resistance, such as alumite, and the cleaning method of a medical device are provided.
<医療器具用洗浄剤組成物>
〔(A)成分〕
本発明の(A)成分はアルカノールアミンである。(A)成分のアルカノールアミンは、変性固着を起こした血液汚染物に対して効果を発揮するとともに、汚れ負荷が多くなった際のpHの低下を抑制する緩衝剤としても作用する。アルカノールアミンとしては、一般式 N(R1)(R2)(R3) で表されるものが挙げられる。R1はOH基を1〜3含む炭素数1〜8の炭化水素基であり、R2、R3は、それぞれ、独立に、水素原子、炭素数1〜4のアルキル基又は炭素数1〜4のアルカノール基である。R1は、炭素数2〜4のアルカノール基が好ましく、R2、R3としては、水素原子が好ましい。前記一般式のアルカノールアミンとしてはモノエタノールアミン、モノプロパノールアミン、モノイソプロパノールアミン、ジエタノールアミン、トリエタノールアミン、N−メチルプロパノールアミン、N−ジメチルエタノールアミン、2−アミノ−2−メチル−1−プロパノール、トリスヒドロキシアミノメタン等が挙げられ中でも、洗浄力の点からモノエタノールアミン、モノプロパノールアミン、モノイソプロパノールアミン、トリスヒドロキシアミノメタンが好ましく、モノエタノールアミンが変性血液汚れの除去性能が高く最も好ましい。
<Cleaning composition for medical device>
[Component (A)]
The component (A) of the present invention is an alkanolamine. The alkanolamine as the component (A) exhibits an effect on the blood contaminants that have undergone denaturation and fixation, and also acts as a buffer that suppresses a decrease in pH when the soil load increases. Examples of the alkanolamine include those represented by the general formula N (R 1 ) (R 2 ) (R 3 ). R 1 is a hydrocarbon group having 1 to 8 carbon atoms containing 1 to 3 OH groups, and R 2 and R 3 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms or 1 to 1 carbon atoms. 4 alkanol groups. R 1 is preferably a C 2-4 alkanol group, and R 2 and R 3 are preferably hydrogen atoms. Examples of the alkanolamine of the general formula include monoethanolamine, monopropanolamine, monoisopropanolamine, diethanolamine, triethanolamine, N-methylpropanolamine, N-dimethylethanolamine, 2-amino-2-methyl-1-propanol, Among these, monoethanolamine, monopropanolamine, monoisopropanolamine, and trishydroxyaminomethane are preferable from the viewpoint of detergency, and monoethanolamine is most preferable because of its high ability to remove denatured blood stains.
(A)成分の含有量は、洗浄液の安定性及び変性血液汚れの除去性能の観点から本発明の医療器具用洗浄剤組成物中、3〜30質量%であり、好ましくは5〜25質量%、さらに好ましくは7〜20質量%の範囲である。 The content of the component (A) is 3 to 30% by mass, preferably 5 to 25% by mass, in the medical device cleaning composition of the present invention from the viewpoint of the stability of the cleaning liquid and the ability to remove denatured blood stains. More preferably, it is the range of 7-20 mass%.
〔(B)成分〕
本発明の(B)成分は非イオン界面活性剤である。(B)成分の非イオン界面活性剤としてはポリオキシアルキレンアルキルエーテル、ポリアルキレングリコール、アルキルアミンオキシド、ポリオキシアルキレンアルキルフェニルエーテル、脂肪酸ポリオキシエチレンエステル、脂肪酸ソルビタンエステル、脂肪酸、ポリオキシアルキレンソルビタンエステル、脂肪酸サッカライドエステル、アルキルポリサッカライド、アルキルグリセリルエーテル、脂肪酸アルカノールアミドなどが挙げられる。タンパク質汚れの除去効果の観点から、下記(1)〜(4)からなる群から選ばれる1種以上の非イオン界面活性剤が好ましい。
[(B) component]
The component (B) of the present invention is a nonionic surfactant. As the nonionic surfactant of component (B), polyoxyalkylene alkyl ether, polyalkylene glycol, alkylamine oxide, polyoxyalkylene alkyl phenyl ether, fatty acid polyoxyethylene ester, fatty acid sorbitan ester, fatty acid, polyoxyalkylene sorbitan ester , Fatty acid saccharide ester, alkyl polysaccharide, alkyl glyceryl ether, fatty acid alkanolamide and the like. From the viewpoint of the effect of removing protein stains, one or more nonionic surfactants selected from the group consisting of the following (1) to (4) are preferred.
(1)下記一般式(1−1)で表されるポリオキシアルキレンエーテル
RO−(AO)s−H (1−1)
(Rは炭素数6〜24の炭化水素基、Aは炭素数2〜4のアルカンジイル基を示す。sはアルカンジイルオキシ基の平均付加モル数を示し、1〜40の数である。)
(2)下記一般式(2−1)〜(2−2)で表されるポリアルキレングリコール
HO−(EO)o−(PO)p−(EO)q−H (2−1)
HO−(PO)p−(EO)q−(PO)r−H (2−2)
(EOはエタンジイルオキシ基、POはプロパンジイルオキシ基を示し、o、p、q、rは平均付加モル数を表し、それぞれ独立して3〜100の数である。)
(3)炭素数6〜16の炭化水素基を有するアルキルアミンオキサイド
(4)炭素数6〜12の炭化水素基を有するアルキルグリセリルエーテル
(1) Polyoxyalkylene ether represented by the following general formula (1-1) RO- (AO) s -H (1-1)
(R represents a hydrocarbon group having 6 to 24 carbon atoms, A represents an alkanediyl group having 2 to 4 carbon atoms. S represents the average number of moles added of the alkanediyloxy group, and is a number from 1 to 40.)
(2) Polyalkylene glycols represented by the following general formulas (2-1) to (2-2) HO— (EO) o — (PO) p — (EO) q —H (2-1)
HO- (PO) p- (EO) q- (PO) r- H (2-2)
(EO represents an ethanediyloxy group, PO represents a propanediyloxy group, and o, p, q, and r represent the average number of moles added, and each independently represents a number of 3 to 100.)
(3) Alkylamine oxide having a hydrocarbon group having 6 to 16 carbon atoms (4) Alkyl glyceryl ether having a hydrocarbon group having 6 to 12 carbon atoms
(1)のポリオキシアルキレンエーテルにおいて、一般式(1−1)のR基は直鎖又は分岐鎖の炭化水素であり、飽和又は不飽和の炭化水素であり、洗浄性、泡特性の観点から、直鎖又は分岐鎖のアルキル基又はアルケニル基が好ましく、直鎖又は分岐鎖のアルキル基がより好ましい。R基の炭素数は6〜24であり、6〜18が好ましく、8〜14がより好ましく、8〜10が更に好ましい。Aは炭素数2〜4のアルカンジイル基であり、洗浄性、泡特性の観点から、炭素数2又は3が好ましい。sはアルカンジイルオキシ基の平均付加モル数を示し、1〜40の数であり、2〜30が好ましく、5〜20がより好ましい。また、複数のアルカンジイル基が含まれる場合には、付加形態は、ブロック付加であってもランダム付加であっても両方が混在していてもよい。 In the polyoxyalkylene ether of (1), the R group of the general formula (1-1) is a linear or branched hydrocarbon, a saturated or unsaturated hydrocarbon, from the viewpoint of detergency and foam characteristics. A linear or branched alkyl group or an alkenyl group is preferable, and a linear or branched alkyl group is more preferable. Carbon number of R group is 6-24, 6-18 are preferable, 8-14 are more preferable, and 8-10 are still more preferable. A is an alkanediyl group having 2 to 4 carbon atoms, and preferably 2 or 3 carbon atoms from the viewpoints of detergency and foam characteristics. s shows the average addition mole number of alkanediyloxy group, is the number of 1-40, 2-30 are preferable and 5-20 are more preferable. When a plurality of alkanediyl groups are included, the addition form may be block addition, random addition, or both.
(1)の好適なポリオキシアルキレンエーテルとして、下記一般式(1−1−1)で表されるポリオキシアルキレンエーテルが挙げられる。
RO−[(EO)l/(PO)m]−H (1−1−1)
(Rは炭素数6〜18の炭化水素基であり、EOはエタンジイルオキシ基、POはプロパンジイルオキシ基を示し、l、mはEO及びPOの平均付加モル数を表し、lは1〜20、mは0〜20の数である。“/”はEOとPOがランダムでもブロックでもよいことを示す記号である。また、EOとPOの付加順序は問わない。)
Examples of suitable polyoxyalkylene ether (1) include polyoxyalkylene ethers represented by the following general formula (1-1-1).
RO-[(EO) l / (PO) m ] -H (1-1-1)
(R is a hydrocarbon group having 6 to 18 carbon atoms, EO represents an ethanediyloxy group, PO represents a propanediyloxy group, l, m represents the average number of added moles of EO and PO, and l represents 1 to 1 20, m is a number from 0 to 20. “/” is a symbol indicating that EO and PO may be random or block, and the order in which EO and PO are added does not matter.)
一般式(1−1−1)で表されるポリオキシアルキレンエーテルのR基は、直鎖でも分岐鎖でもよいが、アルキル基又はアルケニル基が好ましく、アルキル基がより好ましい。R基の炭素数は6〜18であり、6〜14が好ましく、更に8〜14がより好ましい。また、lは1〜20の数であり、2〜15の数が好ましく、2〜10の数がより好ましい。mは0〜20の数であり、1〜20の数が好ましく、2〜15の数がより好ましく、2〜10の数が更に好ましい。またlとmの比は、3/1〜1/3が好ましく、2/1〜1/2がより好ましい。EO及びPOの付加形態は、ランダム付加であってもブロック付加であっても良い。 The R group of the polyoxyalkylene ether represented by the general formula (1-1-1) may be linear or branched, but is preferably an alkyl group or an alkenyl group, and more preferably an alkyl group. The carbon number of the R group is 6 to 18, preferably 6 to 14, and more preferably 8 to 14. Moreover, l is a number of 1-20, the number of 2-15 is preferable, and the number of 2-10 is more preferable. m is a number from 0 to 20, preferably a number from 1 to 20, more preferably a number from 2 to 15, and still more preferably a number from 2 to 10. The ratio of l to m is preferably 3/1 to 1/3, more preferably 2/1 to 1/2. The addition form of EO and PO may be random addition or block addition.
(2)の一般式(2−1)、(2−2)で表されるポリアルキレングリコールにおいて、EOはエタンジイルオキシ基、POはプロパンジイルオキシ基を示し、o、p、q、rは平均付加モル数であり、それぞれ独立して3〜100の数であり、5〜30の数がより好ましい。また(o+q)/pの比又はq/(p+r)の比は、3/1〜1/3が好ましく、2/1〜1/2がより好ましい。一般式(2−1)、(2−2)で表されるポリアルキレングリコールは、例えば、プルロニック、プルロニックRという商品名でBASF社から入手可能である。 In the polyalkylene glycol represented by the general formulas (2-1) and (2-2) in (2), EO represents an ethanediyloxy group, PO represents a propanediyloxy group, and o, p, q, and r are Average number of moles added, each independently a number from 3 to 100, more preferably from 5 to 30. The ratio of (o + q) / p or the ratio of q / (p + r) is preferably 3/1 to 1/3, and more preferably 2/1 to 1/2. The polyalkylene glycols represented by the general formulas (2-1) and (2-2) are available from BASF under the trade names of Pluronic and Pluronic R, for example.
(3)のアミンオキシドは、少なくとも1つの炭素数6〜16の炭化水素基を有しており、炭素数6〜14が好ましく、炭素数8〜12がより好ましい。炭化水素基はアルキル基又はアルケニル基であり、好ましくは直鎖又は分岐鎖アルキル基、より好ましくは直鎖アルキル基を有するアミンオキサイドが好ましい。また、炭素数6〜16の炭化水素基以外の置換基は炭素数1〜3のアルキル基が好ましい。 The amine oxide (3) has at least one hydrocarbon group having 6 to 16 carbon atoms, preferably 6 to 14 carbon atoms, and more preferably 8 to 12 carbon atoms. The hydrocarbon group is an alkyl group or an alkenyl group, preferably an amine oxide having a linear or branched alkyl group, more preferably a linear alkyl group. Moreover, as for substituents other than a C6-C16 hydrocarbon group, a C1-C3 alkyl group is preferable.
(4)のグリセリルエーテルは、炭素数6〜12の炭化水素基を有するものであり、炭化水素基は好ましくは炭素数6〜10、より好ましくは炭素数8〜10である。炭化水素基は、アルキル基又はアルケニル基であり、好ましくは直鎖又は分岐鎖アルキル基、より好ましくは直鎖アルキル基である。 The glyceryl ether (4) has a hydrocarbon group having 6 to 12 carbon atoms, and the hydrocarbon group preferably has 6 to 10 carbon atoms, more preferably 8 to 10 carbon atoms. The hydrocarbon group is an alkyl group or an alkenyl group, preferably a linear or branched alkyl group, more preferably a linear alkyl group.
一般に、医療器具洗浄機、特に内視鏡洗浄機に関しては、洗浄時の水温に温度管理がされていないものが多い。常温で洗浄した場合には、特に泡が問題にならない場合でも、水温が低くなると、泡が消えにくくなる。 In general, there are many medical instrument cleaners, particularly endoscope cleaners, whose temperature is not controlled at the time of cleaning. When washing is performed at room temperature, even when bubbles are not a problem, the bubbles are difficult to disappear when the water temperature is lowered.
一方、洗浄力を高めるために、洗浄機の中では常に高圧で噴出された水が循環しており、非常に泡立ちやすくなっている。泡がたつと、泡により超音波や水流の物理力が緩和され、医療器具表面に伝わりにくくなり洗浄力が低下する。それだけではなく、医療器具の洗浄機に備えられている洗浄水の供給や排出を感知するための水位センサーの誤感知を起こし、洗浄が停止してしまう。また、RO水や、イオン交換水など極端に硬度が低い水を使用したときにも同様の問題が見られる。そのため5℃の低硬度の水を使用した場合でも泡立ちが抑制されていることが好ましい。 On the other hand, in order to increase the cleaning power, the water jetted at a high pressure is constantly circulating in the cleaning machine, and it is very easy to foam. When the bubbles build up, the physical force of ultrasonic waves and water flow is eased by the bubbles, and it becomes difficult to be transmitted to the surface of the medical device and the cleaning power is reduced. In addition, the water level sensor for detecting the supply and discharge of the cleaning water provided in the washing machine of the medical instrument causes false detection and the cleaning is stopped. The same problem is also observed when extremely low hardness water such as RO water or ion exchange water is used. Therefore, it is preferable that foaming is suppressed even when water having a low hardness of 5 ° C. is used.
このような観点から非イオン界面活性剤としては、(1)〜(4)の非イオン界面活性剤の中では、タンパク質汚れの除去効果の観点から、(1)〜(3)からなる群から選ばれる1種以上の非イオン界面活性剤が好ましく、(1)〜(3)を適宜併用して用いてもよい。また、(1)から選ばれる1種以上の非イオン界面活性剤がより好ましい。なかでも、(1)の非イオン界面活性剤のうち、一般式(1−1)中のRが炭素数6〜16の炭化水素基である非イオン界面活性剤が好ましく、Rは炭素数8〜14がより好ましく、より更に炭素数8〜14で分岐鎖を有するものが好ましい。 From such a viewpoint, as the nonionic surfactant, among the nonionic surfactants (1) to (4), from the viewpoint of the effect of removing protein stains, the nonionic surfactant is selected from the group consisting of (1) to (3). One or more selected nonionic surfactants are preferred, and (1) to (3) may be used in combination as appropriate. In addition, one or more nonionic surfactants selected from (1) are more preferable. Among these, among the nonionic surfactants of (1), a nonionic surfactant in which R in the general formula (1-1) is a hydrocarbon group having 6 to 16 carbon atoms is preferable. To 14 are more preferable, and those having 8 to 14 carbon atoms and having a branched chain are more preferable.
(B)成分の含有量は、洗浄力の観点から本発明の医療器具用洗浄剤組成物中、0.5〜20質量%であり、好ましくは1〜10質量%、さらに好ましくは3〜8質量%の範囲である。 (B) Content of a component is 0.5-20 mass% in the cleaning composition for medical devices of this invention from a viewpoint of detergency, Preferably it is 1-10 mass%, More preferably, it is 3-8. It is the range of mass%.
〔(C)成分〕
(C)成分の4価以上の多価アルコールは、ヒドロキシ基を分子中に4〜10個有する化合物が好ましく、窒素原子を含まないものが好ましい。また、(C)成分の炭素数は4〜12、更に5〜8が好ましい。(C)成分としては、ソルビトール、キシリトール、グルコース、エリスリトール、ペンタエリトリトール、トレハロース、マルチトール、スクラロース、ジグリセリン、トリグリセリン、ペンタンテトラオール、ヘキサンテトラオール、オクタンテトラオール、テトラヒドロキシベンゼン等が挙げられる。(C)成分は糖類が好ましく、糖アルコールから選ばれる多価アルコールがより好ましい。また、(C)成分は、還元性のないものが、経時におけるアルカノールアミンとの反応による洗浄剤の着色を防ぐという点から好ましい。さらに、アルマイトの防食の点からより好ましくは、ソルビトール、キシリトールである。
[Component (C)]
As the (C) component tetrahydric or higher polyhydric alcohol, a compound having 4 to 10 hydroxy groups in the molecule is preferable, and a compound containing no nitrogen atom is preferable. Moreover, the carbon number of (C) component is 4-12, Furthermore, 5-8 are preferable. Examples of the component (C) include sorbitol, xylitol, glucose, erythritol, pentaerythritol, trehalose, maltitol, sucralose, diglycerin, triglycerin, pentanetetraol, hexanetetraol, octanetetraol, tetrahydroxybenzene and the like. . The component (C) is preferably a saccharide, more preferably a polyhydric alcohol selected from sugar alcohols. Further, the component (C) is preferably non-reducing from the viewpoint of preventing coloring of the cleaning agent due to reaction with alkanolamine over time. Furthermore, sorbitol and xylitol are more preferable from the viewpoint of anticorrosion of alumite.
(C)成分の含有量は、アルマイトの防食の観点から本発明の医療器具用洗浄剤組成物中、3〜50質量%であり、好ましくは5〜40質量%、さらに好ましく10〜30質量%の範囲である。 The content of the component (C) is 3 to 50% by mass, preferably 5 to 40% by mass, and more preferably 10 to 30% by mass in the cleaning composition for medical devices of the present invention from the viewpoint of anodized anticorrosion. Range.
本発明の医療器具用洗浄剤組成物は、金属の腐食を防ぐためには(A)成分に対して十分な量の(C)成分が必要であり、(C)/(A)質量比、すなわち(A)成分の含有量に対する(C)成分の含有量の比が、0.5以上、更に1〜10、より更に1〜3であることが好ましい。 The medical device cleaning composition of the present invention requires a sufficient amount of the component (C) relative to the component (A) in order to prevent metal corrosion, and the (C) / (A) mass ratio, The ratio of the content of the component (C) to the content of the component (A) is preferably 0.5 or more, more preferably 1 to 10, and still more preferably 1 to 3.
〔その他の成分〕
本発明の医療器具用洗浄剤組成物は、(A)〜(C)成分を高温でも分離することなくより安定に配合できる観点から、(D)炭素数2〜8で、分子中に1〜2個のヒドロキシ基を有する化合物から選ばれる可溶化剤〔以下、(D)成分という〕を含有することが好ましい。(D)成分としては、エタノール、イソプロパノールなどの炭素数1〜4の低級アルコール、メチルセロソルブなどを用いることができるが、好ましくは、炭素数3〜8でヒドロキシ基を分子中に2個有する化合物である。ヒドロキシ基を分子中に2個有する化合物としては、ジプロピレングリコール、1,3−ブチレングリコール、1,2−ブチレングリコール、ジブチレングリコール、1,6−ヘキサンジオール、1,2−ヘキサンジオール、プロピレングリコール等が挙げられる。(D)成分の含有量は、配合安定性の観点から本発明の医療器具用洗浄剤組成物中、好ましくは1〜60質量%、より好ましくは3〜50質量%、さらに好ましくは5〜30質量%の範囲である。
[Other ingredients]
The cleaning composition for medical devices of the present invention has (D) 2 to 8 carbon atoms and 1 to 1 in the molecule from the viewpoint that the components (A) to (C) can be blended more stably without separation even at high temperatures. It preferably contains a solubilizer selected from compounds having two hydroxy groups (hereinafter referred to as component (D)). (D) As a component, although C1-C4 lower alcohol, such as ethanol and isopropanol, methyl cellosolve, etc. can be used, Preferably it is a C3-C8 compound which has two hydroxy groups in a molecule | numerator. It is. Compounds having two hydroxy groups in the molecule include dipropylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, dibutylene glycol, 1,6-hexanediol, 1,2-hexanediol, propylene Glycol and the like. The content of the component (D) is preferably 1 to 60% by mass, more preferably 3 to 50% by mass, and further preferably 5 to 30% in the medical device cleaning composition of the present invention from the viewpoint of blending stability. It is the range of mass%.
本発明の医療器具用洗浄剤組成物は、タンパク質に対する洗浄性を上げる観点から、酵素を含有することができる。酵素としては、プロテアーゼ、アミラーゼ、リパーゼ、セルラーゼ等があげられ、中でもプロテアーゼ、更にアルカリプロテアーゼが好ましい。 The medical device detergent composition of the present invention can contain an enzyme from the viewpoint of improving the detergency for proteins. Examples of the enzyme include protease, amylase, lipase, cellulase and the like. Among them, protease and alkaline protease are preferable.
アルカリプロテアーゼとしては、好ましくは中性からアルカリ側に至適pHが存在するものであれば如何なる酵素でもよく、またこの条件を満たす複数のアルカリプロテアーゼを組合せて使用することが可能である。アルカリプロテアーゼはBacillus SPに由来するズブチリシンプロテアーゼが好ましく、中でも、Bacillus Halodurans、Bacillus clausiiに由来するズブチリシンプロテアーゼが好ましい。市販されているアルカリプロテアーゼとしては、ノボザイムズジャパン社から入手できるアルカラーゼ、サビナーゼ、エバラーゼ、エスペラーゼ、カンナーゼ、オボザイム、ジェネンコア・インターナショナル社から入手できるプラフェクト、プロペラーゼなどがある。また特開2007−61101号公報に記載されたアルカリプロテアーゼも好適に使用できる。 The alkaline protease is preferably any enzyme as long as it has an optimum pH from neutral to alkaline, and a plurality of alkaline proteases satisfying this condition can be used in combination. The alkaline protease is preferably a subtilisin protease derived from Bacillus SP, and among them, a subtilisin protease derived from Bacillus Halodurans or Bacillus clausii is preferred. Examples of commercially available alkaline proteases include Alcalase, Sabinase, Evalase, Esperase, Cannase, Obozyme, and Perfect, Properase available from Genencor International, available from Novozymes Japan. Moreover, the alkaline protease described in JP 2007-61101 A can also be suitably used.
また、本発明で用いる希釈洗浄液中、アルカリプロテアーゼの含有量(タンパク質分解活性)は、固着タンパク質除去効果及びコストの観点から、希釈洗浄液1kgあたり、0.01〜200PUが好ましく、0.05〜100PUがより好ましく、0.1〜50PUがさらに好ましく、0.5〜20PUが特に好ましい。 In addition, the content of alkaline protease (proteolytic activity) in the diluted cleaning solution used in the present invention is preferably 0.01 to 200 PU per kg of diluted cleaning solution, from the viewpoint of the effect of removing the fixed protein and cost, and 0.05 to 100 PU. Is more preferable, 0.1 to 50 PU is more preferable, and 0.5 to 20 PU is particularly preferable.
なお、タンパク質分解活性(PU/g)は次の方法により測定される。
1w/v%の濃度でカゼイン(ハマーステイン:メルク社)を含む50mmol/Lホウ酸緩衝液(pH10.5)1mLを30℃で5分間保温した後、0.1gの酵素溶液と混合し、30℃で15分間反応を行う。反応停止液(0.11mol/Lトリクロロ酢酸−0.22mol/L酢酸ナトリウム−0.33mol/L酢酸)2mLを加え、室温で10分間放置する。次に酸変性タンパク質をろ過(No.2ろ紙;ワットマン社製)し、ろ液0.5mLにアルカリ性銅溶液[1w/v%酒石酸カリウム・ナトリウム水溶液:1w/v%硫酸銅水溶液:炭酸ナトリウムの0.1mol/L水酸化ナトリウム水溶液溶解物(炭酸ナトリウム濃度2w/v%)=1:1:100(V/V)]2.5mLを添加し30℃、10分間保温する。さらに、希釈フェノール試薬[フェノール試薬(関東化学社製)をイオン交換水で2倍に希釈したもの]0.25mLを加え、30℃で30分間保温後、このサンプルの660nmにおける吸光度を測定する。また、上記の酵素反応系に反応停止液を混合した後、酵素溶液を加えたものをブランクとして同様に吸光度を測定する。次にサンプルとブランクとの吸光度差により、遊離してきた酸可溶性のタンパク質分解物量(チロシン換算された量)が得られ、これを反応時間(本条件の場合:15分)及び酵素溶液量(本条件の場合:0.1g)で除して、タンパク質分解活性値を求めることができる。なお、1PUは、上記の反応条件において1分間に1mmolのチロシンに相当する酸可溶性タンパク質分解物を遊離する酵素量とする。
The proteolytic activity (PU / g) is measured by the following method.
1 mL of 50 mmol / L borate buffer solution (pH 10.5) containing casein (Hammerstein: Merck) at a concentration of 1 w / v% was kept at 30 ° C. for 5 minutes, and then mixed with 0.1 g of enzyme solution. The reaction is carried out at 30 ° C. for 15 minutes. Add 2 mL of the reaction stop solution (0.11 mol / L trichloroacetic acid-0.22 mol / L sodium acetate-0.33 mol / L acetic acid) and let stand at room temperature for 10 minutes. Next, the acid-denatured protein was filtered (No. 2 filter paper; manufactured by Whatman), and an alkaline copper solution [1 w / v% potassium tartrate / sodium tartrate aqueous solution: 1 w / v% copper sulfate aqueous solution: sodium carbonate was added to 0.5 mL of the filtrate. 0.1 mol / L aqueous sodium hydroxide solution (sodium carbonate concentration 2 w / v%) = 1: 1: 100 (V / V)] 2.5 mL is added, and the mixture is kept at 30 ° C. for 10 minutes. Further, 0.25 mL of a diluted phenol reagent [phenol reagent (manufactured by Kanto Chemical Co., Ltd.) diluted twice with ion-exchanged water] is added, and the mixture is incubated at 30 ° C. for 30 minutes, and then the absorbance at 660 nm of this sample is measured. Moreover, after mixing a reaction stop liquid with said enzyme reaction system, what added an enzyme solution is measured similarly as a blank. Next, the amount of acid-soluble proteolysate that has been liberated (the amount converted to tyrosine) is obtained from the difference in absorbance between the sample and the blank, and this is the reaction time (in this case: 15 minutes) and the amount of enzyme solution (this In the case of conditions: Dividing by 0.1 g), the proteolytic activity value can be determined. Note that 1 PU is the amount of enzyme that liberates an acid-soluble proteolytic product corresponding to 1 mmol of tyrosine per minute under the above reaction conditions.
この他にも、本発明の医療器具用洗浄剤組成物は、金属封鎖剤、防食剤、着色剤、賦香剤、粘度、調整剤、可溶化剤等の成分を必要に応じて含有することができる。 In addition to this, the cleaning composition for a medical device of the present invention contains components such as a metal sequestering agent, an anticorrosive agent, a colorant, a flavoring agent, a viscosity, a regulator, and a solubilizer as necessary. Can do.
本発明の医療器具用洗浄剤組成物の形態は、液体(分散粒子を含んでいてもよい)であることが好ましい。液体の場合、本発明の医療器具用洗浄剤組成物は、水を好ましくは5〜70質量%、より好ましくは10〜50質量%、更に好ましくは15〜30質量%含有する。また、液体でかつ水を含有する場合、本発明の医療器具用洗浄剤組成物は、25℃のpHが好ましくは10〜13、より好ましく10.5〜12.5、更に好ましくは11〜12である。 The form of the cleaning composition for a medical device of the present invention is preferably a liquid (which may contain dispersed particles). In the case of a liquid, the medical device cleaning composition of the present invention preferably contains 5 to 70% by mass of water, more preferably 10 to 50% by mass, and still more preferably 15 to 30% by mass. Moreover, when it is liquid and contains water, the cleaning composition for medical devices of the present invention preferably has a pH of 25 ° C. of 10 to 13, more preferably 10.5 to 12.5, and still more preferably 11 to 12. It is.
本発明の医療器具用洗浄剤組成物は、そのまま使用してもよいが、通常、該洗浄剤組成物を水で希釈して調製した希釈洗浄液を洗浄に用いる。希釈倍率は限定されないが、通常50倍〜1000倍程度に希釈することが想定される。洗浄力には、洗浄時のpHも重要であり、本発明の医療器具用洗浄剤組成物は、水で200倍に希釈した希釈液のpHが25℃で9.5以上、更に10.0以上であることが望ましい。また、200倍希釈液のpHの上限値は内視鏡や医療器具に用いられている金属類の腐食防止の観点から12以下が好ましい。 The cleaning composition for medical devices of the present invention may be used as it is, but usually a diluted cleaning solution prepared by diluting the cleaning composition with water is used for cleaning. Although the dilution rate is not limited, it is assumed that the dilution is usually about 50 to 1000 times. The pH at the time of cleaning is also important for the cleaning power, and the cleaning composition for medical devices of the present invention has a pH of 9.5 or more at 25 ° C. at a diluted solution diluted 200 times with water, and further 10.0. The above is desirable. The upper limit of the pH of the 200-fold diluted solution is preferably 12 or less from the viewpoint of preventing corrosion of metals used in endoscopes and medical instruments.
本発明の対象となる医療器具としては、剪刀、鉗子、鑷子などの鋼製器具類、カテーテル、チューブ、バイトブロックなどの樹脂製器具、硬性もしくは軟性内視鏡等が挙げられる。本発明の医療器具用洗浄剤組成物は、内視鏡用が好ましい。また、これら医療器具の自動洗浄機用であってもよく、内視鏡の自動洗浄機用であることがより好ましい。 Examples of medical instruments that are the subject of the present invention include steel instruments such as scissors, forceps, and insulators, resin instruments such as catheters, tubes, and bite blocks, and rigid or flexible endoscopes. The medical device cleaning composition of the present invention is preferably used for an endoscope. Moreover, it may be for an automatic washing machine for these medical instruments, and more preferably for an automatic washing machine for an endoscope.
<医療器具の洗浄方法>
本発明の医療器具の洗浄方法では、上記本発明の医療器具用洗浄剤組成物を水で50〜1000倍に希釈した希釈洗浄液を用いて、医療器具洗浄機により医療器具を洗浄する。希釈洗浄液は、(B)成分を0.002〜1質量%含有することが好ましい。また、希釈洗浄液のpHは、9〜12、更に9.5〜11.5、より更に10〜11が好ましい。このような(B)成分含有量やpHとなるように本発明の医療器具用洗浄剤組成物を水で希釈することが好ましい。
<Cleaning method for medical devices>
In the method for cleaning a medical instrument of the present invention, the medical instrument is cleaned by a medical instrument washer using a diluted cleaning solution obtained by diluting the cleaning composition for medical instrument of the present invention 50 to 1000 times with water. The diluted cleaning liquid preferably contains 0.002 to 1% by mass of the component (B). The pH of the diluted cleaning solution is preferably 9 to 12, more preferably 9.5 to 11.5, and even more preferably 10 to 11. It is preferable to dilute the cleaning composition for a medical device of the present invention with water so that the content and pH of the component (B) are such.
表1の医療器具用洗浄剤組成物を調製し、以下の方法で洗浄性とアルマイト防食性を評価した。結果を表1に示す。なお、pHは、堀場製作所製 pHメータ F−21を用いて測定した。 The cleaning composition for medical devices shown in Table 1 was prepared, and the cleaning properties and anodized anticorrosive properties were evaluated by the following methods. The results are shown in Table 1. In addition, pH was measured using HORIBA, Ltd. pH meter F-21.
<洗浄性>
テフロン製のテストピースに、グリセリン、血清、ムチン、小麦粉、サフラニンからなるEN/ISO15883-5 Annex Rに記載のモデル汚れを10mg/cm2の割合で塗布し、室温で1時間乾燥させたものを実験に用いた。洗浄は、オリンパスメディカルシステムズ(株)製内視鏡洗浄消毒器OER-2内に固定し、洗浄時間を10分に設定し洗浄を行った。洗浄終了後、テストピースを取り出し、別に用意した水槽中のイオン交換水を用いて穏やかにすすいだ。乾燥後、目視で汚れの残留があるかを判定した後、目視で残留が認められないものに関しては、Coomassie Protein Assay Reagent(タンパク質定量キット添付の試薬、Thermo Scientific社製)に3分間浸漬後(CBB染色)、イオン交換水で充分濯いだ後の染色状態で下記の判定基準に従い判定した。尚、試験にあたっては5枚のテストピースを用い、結果はその平均値とした。
判定基準
5:目視でも、CBB染色後でも汚れの残留がほとんどみられない。
4:目視では残留が認められないが、CBB染色では、一部にタンパク質の残留が認められる。
3:目視では残留が認められないが、CBB染色では、全面にタンパク質の残留が認められる
2:目視でも僅かに残留が見られる
1:目視で多くの血液の残留が認められる
評価点4以上であれば、再使用にあたっては問題ないレベルであり、良好に洗浄できたものと判断する。
<Cleanability>
A model soil described in EN / ISO15883-5 Annex R consisting of glycerin, serum, mucin, flour and safranin was applied to a Teflon test piece at a rate of 10 mg / cm 2 and dried at room temperature for 1 hour. Used for experiments. The cleaning was carried out by fixing in an endoscope cleaning / disinfecting device OER-2 manufactured by Olympus Medical Systems Co., Ltd., and setting the cleaning time to 10 minutes. After washing, the test piece was taken out and rinsed gently with ion-exchanged water in a separately prepared water tank. After drying, determine whether there is any residual dirt visually, and if there is no visible residue, immerse in Coomassie Protein Assay Reagent (reagent supplied with the protein quantification kit, manufactured by Thermo Scientific) for 3 minutes ( CBB staining), and after rinsing with ion-exchanged water, the dyeing state was determined according to the following criteria. In the test, five test pieces were used, and the result was an average value.
Judgment criteria 5: Residual dirt is hardly observed even visually or after CBB staining.
4: No residue is visually observed, but protein residue is partially observed in CBB staining.
3: No residue is visually observed, but protein residue is observed on the entire surface by CBB staining. 2: A slight residue is visually observed. 1: A large amount of blood is visually observed. If it exists, it is judged that it is at a level where there is no problem in re-use and can be cleaned well.
<アルマイト防食性>
医療器具用洗浄剤組成物を0.5質量%になるようにイオン交換水で希釈し、20gwpガラス製スクリュー管No.7容量50mLに入れ、予め秤量した縦50mm、横20mm、厚み1mmのアルマイト標準試験板(日本テストパネル社製)を、約半分浸漬された状態で、50℃で4日間保存した。保存後、試験板を取り出し、流水中でよく洗浄した後、十分に乾燥させた後、秤量し質量変化を測定した。質量変化が7mg以下のものは、通常の洗浄においては、アルマイトの防食に大きな問題はないものと判断される。
<Anodized corrosion resistance>
The medical device detergent composition was diluted with ion-exchanged water so as to be 0.5% by mass, and a 20 gwp glass screw tube No. A volume of 50 mm, a width of 20 mm, and a thickness of 1 mm of alumite standard test plate (manufactured by Nippon Test Panel Co., Ltd.) weighed in advance was stored for 4 days at 50 ° C. while being immersed in about half. After storage, the test plate was taken out, washed thoroughly in running water, sufficiently dried, weighed, and the change in mass was measured. When the mass change is 7 mg or less, it is judged that there is no significant problem with the corrosion protection of anodized in normal cleaning.
・非イオン界面活性剤:一般式(1−1−1)中、Rが炭素数12〜14の分岐鎖アルキル基、lが7、mが7.5、EOとPOがEO、POの順でブロック配列した非イオン界面活性剤(ソフタノール7085(日本触媒(株)製)) Nonionic surfactant: In general formula (1-1-1), R is a branched alkyl group having 12 to 14 carbon atoms, l is 7, m is 7.5, EO and PO are EO, PO in this order. Nonionic surfactant (Softanol 7085 (manufactured by Nippon Shokubai Co., Ltd.))
Claims (7)
RO−[(EO) l /(PO) m ]−H (1−1−1)
(Rは炭素数6〜18の炭化水素基であり、EOはエタンジイルオキシ基、POはプロパンジイルオキシ基を示し、l、mはEO及びPOの平均付加モル数を表し、lは1〜20、mは1〜20の数である。“/”はEOとPOがランダムでもブロックでもよいことを示す記号である。また、EOとPOの付加順序は問わない。) (A) 3 to 30% by mass of alkanolamine, (B) 0.5 to 20% by mass of a nonionic surfactant represented by the following general formula (1-1-1), and (C) a polyvalent value of 4 or more. A cleaning composition for medical devices containing 3 to 50% by mass of alcohol.
RO-[(EO) l / (PO) m ] -H (1-1-1)
(R is a hydrocarbon group having 6 to 18 carbon atoms, EO represents an ethanediyloxy group, PO represents a propanediyloxy group, l, m represents the average number of added moles of EO and PO, and l represents 1 to 1 20, m is a number from 1 to 20. “/” is a symbol indicating that EO and PO may be random or block, and the addition order of EO and PO is not limited.)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010292238A JP5587168B2 (en) | 2010-12-28 | 2010-12-28 | Cleaning composition for medical equipment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010292238A JP5587168B2 (en) | 2010-12-28 | 2010-12-28 | Cleaning composition for medical equipment |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012140485A JP2012140485A (en) | 2012-07-26 |
JP5587168B2 true JP5587168B2 (en) | 2014-09-10 |
Family
ID=46677107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010292238A Active JP5587168B2 (en) | 2010-12-28 | 2010-12-28 | Cleaning composition for medical equipment |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5587168B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5706153B2 (en) * | 2010-12-28 | 2015-04-22 | 花王株式会社 | Enzyme-containing detergent composition for endoscope washing machine |
WO2012090306A1 (en) | 2010-12-28 | 2012-07-05 | 花王株式会社 | Method for cleaning medical appliance |
BR112016002074B1 (en) * | 2013-07-31 | 2023-01-24 | Intelgenx Corp | QUICKLY DISINTEGRATION AND INSTANTLY WETABLE ORAL FILM FREE OF SURFACTANTS OR POLYALCOHOL |
JP2019014823A (en) * | 2017-07-07 | 2019-01-31 | 日華化学株式会社 | Treatment agent composition before washing living organism stain-adhered appliance, and treatment method before washing living organism stain-adhered appliance |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3929518B2 (en) * | 1995-11-30 | 2007-06-13 | 東京応化工業株式会社 | Stripping composition for resist |
JP2001031999A (en) * | 1999-07-19 | 2001-02-06 | Clean Chemical Kk | Detergent composition |
US7071152B2 (en) * | 2003-05-30 | 2006-07-04 | Steris Inc. | Cleaning and decontamination formula for surfaces contaminated with prion-infected material |
JP4633482B2 (en) * | 2005-01-17 | 2011-02-16 | 花王株式会社 | Medical disinfectant cleaning composition |
JP5033380B2 (en) * | 2006-08-30 | 2012-09-26 | ディバーシー株式会社 | Disinfectant composition and disinfectant cleaning composition for tableware, cooking utensils, food processing plant or kitchen, and sterilization method or disinfecting cleaning method for tableware, cooking utensils, food processing plant or kitchen facilities using the same |
JP5317466B2 (en) * | 2007-12-14 | 2013-10-16 | 花王株式会社 | Cleaning composition for medical equipment |
-
2010
- 2010-12-28 JP JP2010292238A patent/JP5587168B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2012140485A (en) | 2012-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5407001B2 (en) | Cleaning composition for endoscope cleaning machine | |
JP5407002B2 (en) | Cleaning composition for medical instrument washer | |
US9353334B2 (en) | Method for cleaning medical instrument | |
JP6654353B2 (en) | Hard surface cleaning composition and method for cleaning hard surface | |
JP5317466B2 (en) | Cleaning composition for medical equipment | |
JP5584613B2 (en) | Cleaning method for medical equipment | |
KR101399218B1 (en) | Low foaming cleaner | |
CA2660739C (en) | Acidic composition based on a surfactant blend | |
JP5587168B2 (en) | Cleaning composition for medical equipment | |
JP2006265463A (en) | Cleanser composition for automatic dishwasher | |
TWI547557B (en) | And a liquid cleaning agent composition for hard surfaces | |
JP5584614B2 (en) | Cleaning composition for medical equipment | |
TWI548736B (en) | And a liquid cleaning agent composition for hard surfaces | |
JP5706153B2 (en) | Enzyme-containing detergent composition for endoscope washing machine | |
JP5706152B2 (en) | Cleaning composition for endoscope cleaning machine | |
JP2008247980A (en) | Detergent composition for washing dish, and detergent composition for preliminary washing | |
JP2011252160A (en) | Cip cleaning method | |
JP4301382B2 (en) | Acid detergent for beer brewing equipment | |
JP5996822B1 (en) | Cleaning composition for automatic cleaning machine | |
JPH06346259A (en) | Alkali detergent composition | |
JP5798961B2 (en) | Liquid cleaner for bathroom | |
JP2011219610A (en) | Detergent composition for medical appliance | |
JP2006290942A (en) | Hard surface detergent composition | |
CN116490596A (en) | Liquid detergent concentrate, ready-to-use application solution, application and cleaning method | |
JP2020090606A (en) | Detergent composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130905 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140430 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140630 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140722 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140723 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5587168 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |